{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:35:59Z","timestamp":1778639759961,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Genetics and Genomics Advances"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xhgg.2025.100544","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:54:25Z","timestamp":1762955665000},"page":"100544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A national biobank framework for rare diseases: Standardized infrastructure and cross-institutional collaboration accelerating translational innovation in China"],"prefix":"10.1016","volume":"7","author":[{"given":"Weida","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruirui","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xhgg.2025.100544_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrg3555","article-title":"Rare-disease genetics in the era of next-generation sequencing: discovery to translation","volume":"14","author":"Boycott","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xhgg.2025.100544_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1028545","article-title":"Rare disease emerging as a global public health priority","volume":"10","author":"Chung","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.xhgg.2025.100544_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-67144-4_1","article-title":"Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data","volume":"1031","author":"Groft","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.xhgg.2025.100544_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"Nguengang Wakap","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.xhgg.2025.100544_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajhg.2017.01.006","article-title":"The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease","volume":"100","author":"Ramoni","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xhgg.2025.100544_bib6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MOP.0000000000000155","article-title":"The National Institutes of Health undiagnosed diseases program","volume":"26","author":"Tifft","year":"2014","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.xhgg.2025.100544_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.euf.2021.06.002","article-title":"Biorepositories and Databanks for the Development of Novel Biomarkers for Genitourinary Cancer Prevention and Management","volume":"7","author":"Wagner","year":"2021","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.xhgg.2025.100544_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41684-024-01395-2","article-title":"Model matchmaking via the Solve-RD Rare Disease Models & Mechanisms Network (RDMM-Europe)","volume":"53","author":"Ellwanger","year":"2024","journal-title":"Lab Anim."},{"key":"10.1016\/j.xhgg.2025.100544_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s13023-021-02130-7","article-title":"National Rare Diseases Registry System (NRDRS): China's first nation-wide rare diseases demographic analyses","volume":"16","author":"Guo","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xhgg.2025.100544_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13023-023-02847-7","article-title":"Physicians' use and perceptions of genetic testing for rare diseases in China: a nationwide cross-sectional study","volume":"18","author":"Liu","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xhgg.2025.100544_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.31887\/DCNS.2016.18.3\/dgurwitz","article-title":"Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders","volume":"18","author":"Gurwitz","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.xhgg.2025.100544_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12864-020-06966-4","article-title":"Genetic variants modulate gene expression statin response in human lymphoblastoid cell lines","volume":"21","author":"Theusch","year":"2020","journal-title":"BMC Genom."},{"key":"10.1016\/j.xhgg.2025.100544_bib13","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1093\/hmg\/ddx320","article-title":"LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease","volume":"26","author":"Howlett","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xhgg.2025.100544_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ccr.2014.07.026","article-title":"Targeted activation of human Vgamma9Vdelta2-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease","volume":"26","author":"Xiang","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xhgg.2025.100544_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13041-016-0267-6","article-title":"Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines","volume":"9","author":"Fujimori","year":"2016","journal-title":"Mol. Brain"},{"key":"10.1016\/j.xhgg.2025.100544_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/tpj.2016.30","article-title":"Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner","volume":"16","author":"Theusch","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.xhgg.2025.100544_bib17","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2174\/1566524011313050010","article-title":"Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine","volume":"13","author":"Shtrichman","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.xhgg.2025.100544_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092319","article-title":"Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening","volume":"10","author":"Aboul-Soud","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xhgg.2025.100544_bib19","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.stem.2023.04.017","article-title":"Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery","volume":"30","author":"Morimoto","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xhgg.2025.100544_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104391","article-title":"Therapeutic development for Canavan disease using patient iPSCs introduced with the wild-type ASPA gene","volume":"25","author":"Chao","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.xhgg.2025.100544_bib21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41392-022-01024-9","article-title":"Human organoids in basic research and clinical applications","volume":"7","author":"Tang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xhgg.2025.100544_bib22","article-title":"Application of an iPSC-Derived Organoid Model for Localized Scleroderma Therapy","volume":"9","author":"Ma","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xhgg.2025.100544_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl3674","article-title":"Personalized chordoma organoids for drug discovery studies","volume":"8","author":"Al Shihabi","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xhgg.2025.100544_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41536-024-00349-z","article-title":"hUC-MSCs-derived MFGE8 ameliorates locomotor dysfunction via inhibition of ITGB3\/NF-kappaB signaling in an NMO mouse model","volume":"9","author":"Xu","year":"2024","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.xhgg.2025.100544_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1703650","article-title":"Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)","volume":"30","author":"Koc","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.xhgg.2025.100544_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.bbmt.2004.06.001","article-title":"Replacement of recipient stromal\/mesenchymal cells after bone marrow transplantation using bone fragments and cultured osteoblast-like cells","volume":"10","author":"Cahill","year":"2004","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.xhgg.2025.100544_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1406829","article-title":"TBX6 null variants and a common hypomorphic allele in congenital scoliosis","volume":"372","author":"Wu","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xhgg.2025.100544_bib28","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/ajmg.a.61607","article-title":"KIAA1217: A novel candidate gene associated with isolated and syndromic vertebral malformations","volume":"182","author":"Al Dhaheri","year":"2020","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.xhgg.2025.100544_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.101940","article-title":"Establishment of an induced pluripotent stem cell line from a patient with hereditary transthyretin amyloidosis carrying transthyretin (TTR) mutation p.Phe53Val","volume":"48","author":"Shan","year":"2020","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.xhgg.2025.100544_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.102022","article-title":"Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation","volume":"49","author":"He","year":"2020","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.xhgg.2025.100544_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/iovs.65.2.17","article-title":"Genotype-Phenotype Associations in an X-Linked Retinoschisis Patient Cohort: The Molecular Dynamic Insight and a Promising SD-OCT Indicator","volume":"65","author":"Wei","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.xhgg.2025.100544_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.65.4.25","article-title":"Longitudinal Natural History Study of Visual Function in Bietti Crystalline Dystrophy: Implications for Early Intervention","volume":"65","author":"Han","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.xhgg.2025.100544_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41419-023-05557-x","article-title":"Aldehyde dehydrogenase 2 alleviates mitochondrial dysfunction by promoting PGC-1alpha-mediated biogenesis in acute kidney injury","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xhgg.2025.100544_bib34","article-title":"Aldehyde Dehydrogenase 2 Lactylation Aggravates Mitochondrial Dysfunction by Disrupting PHB2 Mediated Mitophagy in Acute Kidney Injury","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xhgg.2025.100544_bib35","article-title":"Structural and biochemical basis of methylmalonate semialdehyde dehydrogenase ALDH6A1","volume":"1","author":"Su","year":"2024","journal-title":"Med. Plus"},{"key":"10.1016\/j.xhgg.2025.100544_bib36","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1038\/s41467-024-52102-1","article-title":"Insights into the assembly of the neovaginal microbiota in Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome patients","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xhgg.2025.100544_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-025-01014-1","article-title":"Whole-genome sequencing susses out rare diseases","author":"Keener","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xhgg.2025.100544_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/gim.0b013e318232a005","article-title":"The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases. Genetics in medicine","volume":"14","author":"Gahl","year":"2012","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2025.100544_bib39","doi-asserted-by":"crossref","DOI":"10.1007\/s12038-024-00430-1","article-title":"Rare genetic diseases in India: Steps toward a nationwide mission program","volume":"49","author":"Kar","year":"2024","journal-title":"J. Biosci."},{"key":"10.1016\/j.xhgg.2025.100544_bib40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s13023-023-02966-1","article-title":"International Undiagnosed Diseases Programs (UDPs): components and outcomes","volume":"18","author":"Curic","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xhgg.2025.100544_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13023-024-03030-2","article-title":"Coding undiagnosed rare disease patients in health information systems: recommendations from the RD-CODE project","volume":"19","author":"Angin","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xhgg.2025.100544_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","article-title":"Whole-genome sequencing of patients with rare diseases in a national health system","volume":"583","author":"Turro","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xhgg.2025.100544_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13023-018-0942-z","article-title":"Impact of biobanks on research outcomes in rare diseases: a systematic review","volume":"13","author":"Garcia","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xhgg.2025.100544_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/bio.2012.1113","article-title":"The human bioresource consortium technical chapter (Japanese association for human bio-resource research)","volume":"11","year":"2013","journal-title":"Biopreserv Biobank"},{"key":"10.1016\/j.xhgg.2025.100544_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13577-018-0204-3","article-title":"The Rare Disease Bank of Japan: establishment, current status and future challenges","volume":"31","author":"Tada","year":"2018","journal-title":"Hum. Cell"},{"key":"10.1016\/j.xhgg.2025.100544_bib46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1750-1172-8-129","article-title":"Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases","volume":"8","author":"Filocamo","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xhgg.2025.100544_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/bio.2020.0108","article-title":"An Overview of Benefits and Challenges of Rare Disease Biobanking in Africa, Focusing on South Africa","volume":"19","author":"Conradie","year":"2021","journal-title":"Biopreserv. Biobank."}],"container-title":["Human Genetics and Genomics Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247725001472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247725001472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:36:18Z","timestamp":1773848178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666247725001472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666247725001472"],"URL":"https:\/\/doi.org\/10.1016\/j.xhgg.2025.100544","relation":{},"ISSN":["2666-2477"],"issn-type":[{"value":"2666-2477","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A national biobank framework for rare diseases: Standardized infrastructure and cross-institutional collaboration accelerating translational innovation in China","name":"articletitle","label":"Article Title"},{"value":"Human Genetics and Genomics Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xhgg.2025.100544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society of Human Genetics.","name":"copyright","label":"Copyright"}],"article-number":"100544"}}